Stockreport

GE HealthCare (GEHC) Begins Phase 2/3 Trial for Innovative MRI Contrast Agent [Yahoo! Finance]

GE Aerospace  (GE) 
Last ge aerospace earnings: 4/30 04:02 pm Check Earnings Report
US:NYSE Investor Relations: ge.com/investor-relations/overview
PDF reached a clinical milestone with the first patient dosed in the Phase 2/3 LUMINA trial for mangaciclanol, an innovative manganese-based MRI contrast agent. The trial, c [Read more]